Gilead Sciences Inc (NASDAQ:GILD)
During the Trading Day
| 55.48 |  -0.45 / -0.80% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 55.63 |  +0.15 / +0.27% |
Volume: 138.2K |
Latest GILD News | Press Releases
| Gilead's Sofosbuvir under European Review - Analyst Blog May 22 / Zacks.com | Cramer's Top Stock Picks: SAVE GILD BMY HTA TSLA May 21 / TheStreet.com |
| This Is Incredibly Bullish Behavior May 22 / TheStreet.com | 5 Stocks Underperforming Today In The Drugs Industry May 20 / TheStreet.com |
| Gilead Stock Hits New 52-Week High (GILD) May 22 / TheStreet.com | 'Mad Money' Lightning Round: Magnum Hunter Blew It May 17 / TheStreet.com |
| M2M case study: Drug effectiveness receives boost May 21 / FT.com | Pipeline Progress at Gilead - Analyst Blog May 16 / Zacks.com |
| Gilead Sciences Inc (GILD): Today's Featured Drugs Winner May 21 / TheStreet.com | Stock Market News for May 14, 2013 - Market News May 14 / Zacks.com |
Today’s Trading
| Previous close | 55.93 |
| Today’s open | 54.89 |
| Day’s range | 54.16 - 56.06 |
| Volume | 10,769,704 |
| Average volume (3 months) | 11,843,586 |
| Market cap | $85.3B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -7.61% |
| Earnings growth (this year) | +0.48% |
| Earnings growth (next 5 years) | +25.50% |
| Revenue growth (last year) | +13.58% |
| P/E ratio | 31.0 |
| Price/Sales | 5.79 |
| Price/Book | 9.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMGNAmgen Inc | +1.09 | +1.04% |
| BIIBBiogen Idec Inc | -0.45 | -0.19% |
| BAXBaxter International... | -0.15 | -0.21% |
| LIFELife Technologies Co... | -0.16 | -0.22% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $0.50 |
| Annual revenue (last year) | $9.6B |
| Annual profit (last year) | $2.6B |
| Net profit margin | 26.96% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer John C. Martin, PhD, MBA |
President & Chief Operating Officer John F. Milligan, PhD |
Corporate headquarters Foster City, California |
Forecasts
